WAVE Clinical Platform is an AI-enabled medical device from Excel Medical Electronics, LLC that the U.S. FDA cleared through 510(k) K171056 on January 4, 2018. Its lead review panel is Cardiovascular and its primary product code is MWI (Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)).
See also FDA-cleared AI cardiovascular devices in 2018, all FDA AI clearances in 2018, top cardiovascular AI devices.
Key facts
| Submission number | K171056 |
|---|---|
| Pathway | 510(k) |
| Date of final decision | |
| Company (FDA list) | Excel Medical Electronics, LLC |
| Lead review panel | Cardiovascular |
| Primary product code | MWI — Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms) |
| Applicant (openFDA) | Excel Medical Electronics, LLC |
| Applicant location | Jupiter, FL, US |
| Device class | Class 2 |
| Regulation number | 21 CFR 870.2300 |
| Decision code | SESE |
| Submission type | Traditional |
Source: FDA AI-Enabled Medical Devices list and openFDA.
What this means
A 510(k) is a premarket submission showing the device is substantially equivalent to a legally marketed predicate device. A cleared 510(k) means FDA agreed with that equivalence. WAVE Clinical Platform went through this pathway (K171056).
openFDA lists it as a Class 2 device under 21 CFR 870.2300. Class II devices are moderate risk and are subject to general and special controls.
Product code MWI covers 5 devices on the FDA AI list. By decision date, this device is #1 of 5 under that code. Excel Medical Electronics, LLC has 1 AI-enabled device on the list, and the Cardiovascular panel accounts for 154 in total.
Being on this list doesn't describe how well the device works clinically. Check the FDA record for its indications for use.